FDA Inspection 1220541 — Archimica S.p.A

Archimica S.p.A — FEI 3002874947

The FDA completed an inspection of Archimica S.p.A on June 15, 2023 in Lodi. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 15, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Lodi (Italy)

Additional Details

Mutual Recognition Agreement (MRA)